Overview
Cortivision is developing a non-invasive visual cortex stimulation device for the restoration of partial vision in people with visual impairment due to retinal and optic nerve disease. Their TMS-based neuromodulation approach targets the visual cortex to augment remaining visual function.
More in Neurodiagnostics
Latest industry news
FDA Grants De Novo Approval to Modius Spero, Clearing First Neuromodulation Device for PTSD
2026-09-03 · Policy
Butterfly Network's BCI Chip Licensing Deal Rattles Investors as Shares Drop Nearly 10%
2026-09-02 · Industry
Merge Labs and Butterfly Network Unite to Push Ultrasound-Based BCIs Into the Mainstream
2026-09-01 · Industry
FDA Grants CorTec Second Breakthrough Device Designation for Its Brain-Computer Interface
2026-08-31 · Policy
Company details
Category
🔬 Neurodiagnostics
Location
Gothenburg, Sweden
Funding
Seed · $3M
Website
cortivision.comListed
2026-06-15
Is this your company?
Claim this listing to add your logo, full description, team, and products. Premium listings get featured placement.
Claim & upgrade listingAdvertise
Reach neurotech professionals
Newsletter sponsorships, featured listings, and sponsored articles.
View packages →